Attached files

file filename
EX-31.3 - EX-31.3 - Dare Bioscience, Inc.ceru-ex313_8.htm
10-K/A - 10-K/A - Dare Bioscience, Inc.ceru-10ka_20161231.htm

Exhibit 31.4

 

CERTIFICATIONS

 

I, Gregg D. Beloff, certify that:

1. I have reviewed this Amendment No. 1 on Form 10-K/A to the Annual Report on Form 10-K for the year ended December 31, 2016 of Cerulean Pharma Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

 

 

 

 

 

Date: April 28, 2017

 

By:

 

/s/ Gregg D. Beloff

 

 

 

 

Gregg D. Beloff

 

 

 

 

Interim Chief Financial Officer

 

 

 

 

(Principal Financial Officer)